News Release Highlights:
Strengthened Balance Sheet: In 2024, Battery X Metals successfully raised $1.77 million through non-brokered financings, reduced liabilities by $1.28 million via equity conversions and renegotiated contractual obligations, and significantly improved its overall capital structure and working capital position.
Technological Innovations: In 2024, the Company advanced its eco-friendly froth flotation technology in partnership with a globally recognized Top 20 University. This effort focused on developing methods to recover battery-grade graphite and other critical materials from end-of-life lithium-ion batteries.
Battery-Technology Portfolio Expansion: In 2024, Battery X Metals acquired a 49% ownership stake in Li-ion Battery Renewable Technologies Inc. (LIBRT). LIBRT achieved key milestones in its proprietary battery diagnostics and rebalancing technologies, setting the stage for future development and commercialization.
Exploration Acquisitions & Results: In 2024, the Company secured 100% ownership of two lithium exploration projects in Quebec, spanning approximately 7,000 hectares (~17,297 acres) in key mining regions. It also advanced exploration at the Belanger Project in Red Lake, Ontario, targeting gold and copper. The Company holds an option to acquire 100% ownership of the Belanger Project, subject to a 3% net smelter royalty.
Vision for 2025: Battery X Metals is focused on advancing the development and validation of battery-grade graphite and critical material recovery technologies, expanding exploration efforts to meet the growing demand for battery and critical minerals, and LIBRT is focused on accelerating the commercialization of its proprietary battery diagnostics and rebalancing solutions, The Company remains committed to driving sustainable innovation in
Read More
Loop Industries supplied 100% recycled, virgin-quality Polyester chips derived from low-value textile waste.
Hyosung TNC transformed Loop Polyester chips into high-performance drawn textured yarn.
Pleatsmama crafted stylish, eco-friendly handbags emphasizing circular design principles.
Loop Industries a fourni de la résine de polyester 100 % recyclée, de qualité vierge, dérivés de déchets textiles de faible valeur.
Hyosung a transformé la résine de polyester Loop en fil texturé étiré à haute performance.
Pleatsmama a créé des sacs à main élégants et écologiques, en mettant l'accent sur les principes de conception circulaire.
Comminution analyses indicate significant processing efficiency gains
HIGHLIGHTS
July 2024 Initial Scoping Study (ISS) validated efficiencies of scale, with a 5Mtpa producing ~130,000oz gold per annum at a competitive All-in-Sustaining-Cost (AISC) of A$1,917/oz Au[1]
Optimised Scoping Study (OSS) commenced November 2024, with key objectives to reduce power consumption, improve economics, and de-risk project working capital requirements[2]
Other OSS work programs underway include updated JORC Mineral Resources Estimate (MRE) block modelling, comminution testwork and scenario analyses, capex and opex optimisation, preliminary power options analyses, and open pit mine design and scheduling opportunities
Comminution testwork and scenario analyses now complete, with meaningful efficiency gains indicated; other programs remain underway, with OSS to be completed before 30 June 2025
As the ‘Purple Peel Exploit' trend takes social media by storm, consumer interest in Mitolyn skyrockets - raising questions, insights, and industry reactions in this latest investigative report.
Read More
The launch of Mochi marks a significant expansion of Babbily's capabilities. Mochi intelligently processes and synthesizes vast amounts of web data with superior precision, ensuring users receive the most relevant, well-grounded information at record speeds.
Read More● Enters a Fast-Growing Business Sector with a Primary $15 Billion TAM and 19% CAGRs
● Expects its Disruptive Digital Telecom Software and Services Business Revenue to Accelerate in 2025 and Beyond
● Company Initially Targets $5 Million Monthly Revenue Run Rate for Q2 and $10 Million Monthly Revenue Run Rate in Q3
$165.0 million icotrokinra (formerly JNJ-2113) milestone earned in Q4 2024, received in January 2025
PN-881, a potential best-in-class oral IL-17 receptor antagonist peptide nominated as a development candidate in Q4 2024
Topline results for rusfertide Phase 3 VERIFY clinical trial in polycythemia vera expected in March 2025
Topline results for icotrokinra Phase 2b ANTHEM clinical trial in moderate to severe ulcerative colitis expected in March 2025
Cash, cash equivalents, and marketable securities of $559.2 million as of December 31, 2024, combined with $165.0 million milestone payment, anticipated to provide cash runway through at least end of 2028
Read More
